Jabbar Seema B, Monaghan Sara, Chen Weina, Koduru Prasad, Kumar Kirthi
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
Lab Med. 2017 Nov 8;48(4):376-380. doi: 10.1093/labmed/lmx034.
Recurrent cytogenetic abnormalities and/or molecular aberrations play an important role in the diagnosis and prognostification of acute myeloid leukemia (AML). We describe a case of a 40 year old woman diagnosed with de novo AML with a novel t(7;14)(q21,q32) and trisomy 4 with poor clinical outcome. Methods: Morphologic, flow cytometry and cytogenetic results of the patient's peripheral blood and bone marrow samples were analyzed.
The diagnostic bone marrow was hypercellular for age (>95%) with increased blasts (62%) that by flow cytometry exhibited myeloid differentiation with a few T/NK lineage markers. Cytogenetics showed a t(7;14)(q21,q32) and trisomy 4. The patient had extremely poor response to two rounds of induction chemotherapy with persistent leukemia following therapy.
To the best of our knowledge, the t(7;14) is a novel cytogenetic abnormality that has not been reported previously in acute myeloid leukemia, and is important to report as it appears to be associated with poor prognosis.
复发性细胞遗传学异常和/或分子畸变在急性髓系白血病(AML)的诊断和预后评估中起着重要作用。我们描述了一例40岁女性,诊断为新发AML,伴有一种新的t(7;14)(q21,q32)和4号染色体三体,临床预后较差。方法:分析患者外周血和骨髓样本的形态学、流式细胞术和细胞遗传学结果。
诊断性骨髓按年龄计算细胞过多(>95%),原始细胞增多(62%),流式细胞术显示其具有髓系分化,并带有一些T/NK谱系标志物。细胞遗传学显示存在t(7;14)(q21,q32)和4号染色体三体。该患者对两轮诱导化疗反应极差,治疗后白血病持续存在。
据我们所知,t(7;14)是一种新的细胞遗传学异常,此前在急性髓系白血病中尚未见报道,因其似乎与不良预后相关,故予以报道很重要。